CN115227748A - Lucid ganoderma and lance asiabell root compound enzyme and preparation method thereof - Google Patents
Lucid ganoderma and lance asiabell root compound enzyme and preparation method thereof Download PDFInfo
- Publication number
- CN115227748A CN115227748A CN202210846398.5A CN202210846398A CN115227748A CN 115227748 A CN115227748 A CN 115227748A CN 202210846398 A CN202210846398 A CN 202210846398A CN 115227748 A CN115227748 A CN 115227748A
- Authority
- CN
- China
- Prior art keywords
- ganoderma
- rice vinegar
- lance
- white
- lance asiabell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000222336 Ganoderma Species 0.000 title claims abstract description 65
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 39
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 150000001875 compounds Chemical class 0.000 title claims description 16
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 47
- 235000009566 rice Nutrition 0.000 claims abstract description 47
- 239000000052 vinegar Substances 0.000 claims abstract description 47
- 235000021419 vinegar Nutrition 0.000 claims abstract description 47
- 235000013601 eggs Nutrition 0.000 claims abstract description 28
- 241000237858 Gastropoda Species 0.000 claims abstract description 22
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 22
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 19
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 17
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 17
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 17
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 17
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 17
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 17
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 17
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 17
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 17
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 17
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 17
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 17
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 17
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 17
- 235000011477 liquorice Nutrition 0.000 claims abstract description 17
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 13
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 11
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000012907 honey Nutrition 0.000 claims abstract description 9
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000010447 xylitol Nutrition 0.000 claims abstract description 9
- 239000000811 xylitol Substances 0.000 claims abstract description 9
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 9
- 229960002675 xylitol Drugs 0.000 claims abstract description 9
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 7
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 7
- 150000005846 sugar alcohols Chemical class 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 4
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 6
- 241000209094 Oryza Species 0.000 claims description 46
- 244000241872 Lycium chinense Species 0.000 claims description 21
- 238000002791 soaking Methods 0.000 claims description 20
- 240000008397 Ganoderma lucidum Species 0.000 claims description 17
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 15
- 238000005303 weighing Methods 0.000 claims description 15
- 241000723353 Chrysanthemum Species 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 11
- 238000004140 cleaning Methods 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 238000007789 sealing Methods 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 8
- 238000011049 filling Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000003860 storage Methods 0.000 claims description 5
- 239000004386 Erythritol Substances 0.000 claims description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 3
- 235000019414 erythritol Nutrition 0.000 claims description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 3
- 229940009714 erythritol Drugs 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 7
- 210000004351 coronary vessel Anatomy 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 238000007865 diluting Methods 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 11
- 239000002131 composite material Substances 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000011435 rock Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000237369 Helix pomatia Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Otolaryngology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Vascular Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
Abstract
The invention relates to the field of health-care medicines, in particular to a ganoderma and lance asiabell root complex enzyme and a preparation method thereof, wherein the ganoderma and lance asiabell root complex enzyme comprises the following raw materials in percentage by weight: 5-8% of glossy ganoderma and Chinese snail eggs, 2-3% of black wolfberry fruits, 1.5-2% of white chrysanthemum or wild chrysanthemum flowers, 1-2% of liquorice, 1-2% of honeysuckle, 1-2% of dry hawthorn slices, 24-28% of red fresh sugar alcohol, 24-28% of honey or xylitol and 58-60% of white rice vinegar. The health-care tea is refined by combining the modern bioengineering technology with the traditional Chinese medicine culture theory and adopting a scientific and reasonable method, has certain curative effects of clearing intestinal tracts, relieving and moistening throat, clearing away heat and toxic materials, expanding coronary vessels, clearing toxin in blood, reducing blood pressure, diluting blood fat, reducing blood sugar, protecting liver, relieving and preventing canceration of the intestinal tracts and the like, and has good taste, convenient eating, simple and convenient preparation method and strong practicability.
Description
Technical Field
The invention relates to the field of health-care medicines, and in particular relates to a ganoderma and conch composite enzyme and a preparation method thereof.
Background
With the continuous development of modern medical and bioengineering technologies and the continuous improvement of living standards of people, people are more and more concerned about their own life health, so that various biological health care products are gradually brought into the market, and particularly the market share of various nutritional health care oral liquids is very large. However, most of the various oral liquids popular in the market are mainly used for simply supplementing nutrition, have single effect, and are difficult to promote the metabolism of histiocyte in human body so as to improve the immunity and the disease prevention and resistance of the human body, so that the consumption requirements of consumers on the products and the functions thereof are difficult to meet.
Disclosure of Invention
The invention aims to provide a lucid ganoderma and lance asiabell root compound enzyme and a preparation method thereof, wherein the lucid ganoderma and lance asiabell root compound enzyme is prepared by combining a modern bioengineering technology with a traditional Chinese medicine culture theory and adopting a scientific and reasonable method, and has the advantages of certain curative effects of clearing intestinal tracts, relieving and moistening throat, clearing away heat and toxic materials, expanding coronary vessels, clearing toxin in blood, reducing blood pressure, diluting blood fat, reducing blood sugar, protecting liver, relieving and preventing canceration of the intestinal tracts and the like, good taste, convenience for eating, simple and convenient preparation method and strong practicability.
In order to solve the problems, the invention relates to a ganoderma and conch composite enzyme and a preparation method thereof, which adopt the following technical scheme: the ganoderma and lance rock composite enzyme comprises the following raw materials in percentage by weight: 5-8% of glossy ganoderma and Chinese snail eggs, 2-3% of black wolfberry fruits, 1.5-2% of white chrysanthemum or wild chrysanthemum flowers, 1-2% of liquorice, 1-2% of honeysuckle, 1-2% of dry hawthorn slices, 24-28% of red fresh sugar alcohol, 24-28% of honey or xylitol and 58-60% of white rice vinegar.
Preferably, the feed comprises the following raw materials in percentage by weight: 5% of glossy ganoderma and Chinese wolfberry fruit, 2% of white chrysanthemum, 1% of liquorice, 1% of honeysuckle, 1% of dry hawthorn slice, 28% of red fresh sugar alcohol and 60% of white rice vinegar.
Preferably, the feed comprises the following raw materials in percentage by weight: 6% of glossy ganoderma and Chinese wolfberry fruit, 3% of black wolfberry fruit, 2% of wild chrysanthemum flower, 2% of liquorice, 2% of honeysuckle, 2% of dry hawthorn slice, 25% of honey and 58% of white rice vinegar.
Preferably, the feed comprises the following raw materials in percentage by weight: 8% of glossy ganoderma and Chinese wolfberry fruit, 2% of black wolfberry fruit, 1.5% of white chrysanthemum, 1.5% of liquorice, 1.5% of honeysuckle, 1.5% of dry hawthorn slices, 24% of xylitol and 60% of white rice vinegar.
A preparation method of a ganoderma and lance asiabell compound enzyme comprises the following steps:
(1) Preparing lucid ganoderma and snail egg rice vinegar extracting solution
Weighing 5-8% of glossy ganoderma and trumpet shell eggs by weight, cleaning, stirring and grinding, weighing 10-15% of rice vinegar, putting the stirred and ground glossy ganoderma and trumpet shell eggs into the rice vinegar for soaking for 15-30 days, filtering the soaking solution by using a fine sieve of 200-360 meshes, and collecting the filtrate for later use;
(2) Preparation of plant Chinese medicinal rice vinegar extract
Weighing 2-3% of black wolfberry, 1.5-2% of white chrysanthemum, 1-2% of hawthorn slices, 1-2% of liquorice and 1-2% of honeysuckle according to weight percentage, respectively cleaning and airing, putting into 45-48% of rice vinegar for soaking for 15-30 days, stirring for 1-3 times every 1-5 days during soaking, filtering by using a 360-mesh sieve of minus 200 meshes, and collecting filtrate for later use;
(3) Preparation of lucid ganoderma and concha delavayi complex enzyme
Adding the ganoderma and lance asiabell egg rice vinegar extract and the plant traditional Chinese medicine rice vinegar extract obtained in the steps (1) and (2) into 24-28 wt% of erythritol, honey or xylitol, uniformly stirring, sealing and fermenting for 15 days, then placing into a storage tank, sterilizing, filling into a finished product bottle, and sealing and packaging to obtain the ganoderma and lance asiabell complex enzyme.
The invention has the following beneficial effects: the invention discloses a lucid ganoderma and lance asiabell root compound enzyme and a preparation method thereof, the compound enzyme has the advantages of reasonable proportion, novel components, simple and convenient preparation method, easy obtainment, certain curative effects of clearing intestinal tracts, relieving and moistening throat, clearing away heat and toxic materials, expanding coronary arteries, clearing toxins in blood, reducing blood pressure, diluting blood fat, reducing blood sugar, protecting liver, relieving and preventing canceration of the intestinal tracts and the like, good taste, convenient eating, simple preparation method, and strong practicability.
Lucid ganoderma and wild snail: the terrestrial shellfish, ganoderma mountain snail, is a special edible snail in original forest, so called Ganoderma mountain snail. The powder of wild ganoderma lucidum broken by ants and flowing down is called ganoderma lucidum powder, and the wild ganoderma lucidum is overgrown with a layer of powder called spore powder, which are foods loved by ganoderma lucidum snails, and the ganoderma lucidum snails have very high nutritional value, and have been reported to be found in Wuzhishan city Mao Nacun on the network of civil government officials of Shanghai province, the ganoderma lucidum snails have extremely high nutritional value and medicinal value, and have wide market prospect. The ganoderma and the lance asiabell can be artificially cultured. The glossy ganoderma and lance snail eggs are eggs produced by glossy ganoderma and lance snails which are obtained through deep domestication and careful cultivation in the artificial cultivation process.
Detailed Description
In order to make the technical purpose, technical solutions and advantageous effects of the present invention more clear, the technical solutions of the present invention are further described below with reference to specific embodiments.
Example 1: a ganoderma and lance snail complex enzyme comprises the following raw materials in percentage by weight: 5% of glossy ganoderma and Chinese wolfberry fruit, 2% of white chrysanthemum, 1% of liquorice, 1% of honeysuckle, 1% of dry hawthorn slice, 28% of red fresh sugar alcohol and 60% of white rice vinegar.
A preparation method of a ganoderma and lance asiabell compound enzyme comprises the following steps:
(1) Preparation of glossy ganoderma and Chinese snail egg rice vinegar extract
Weighing 5% of glossy ganoderma and trumpet shell eggs by weight, cleaning, stirring and grinding, weighing 15% of rice vinegar, putting the stirred glossy ganoderma and trumpet shell eggs into the rice vinegar for soaking for 15 days, filtering a soaking solution by using a fine sieve of 200 to 360 meshes, and collecting a filtrate for later use;
(2) Preparation of plant traditional Chinese medicine rice vinegar extract
Weighing 2% of black wolfberry fruit, 2% of feverfew, 1% of hawthorn slice, 1% of liquorice and 1% of honeysuckle by weight percentage, respectively cleaning and airing, putting into 45% of rice vinegar by weight percentage, soaking for 15 days, stirring for 1 time every 5 days during soaking, filtering by using a 200-to-360-mesh fine sieve, and collecting filtrate for later use;
(3) Preparation of lucid ganoderma and concha delavayi complex enzyme
And (3) adding the ganoderma and lance asiabell egg rice vinegar extract and the plant traditional Chinese medicine rice vinegar extract obtained in the steps (1) and (2) into 28 wt% of erythritol, uniformly stirring, sealing and fermenting for 15 days, putting into a storage tank, sterilizing, filling into a finished product bottle, and sealing and packaging to obtain the ganoderma and lance asiabell compound enzyme.
Example 2: this example differs from example 1 in that: the ganoderma and lance rock composite enzyme comprises the following raw materials in percentage by weight: 6% of glossy ganoderma and Chinese wolfberry fruit, 3% of wild chrysanthemum flower, 2% of liquorice, 2% of honeysuckle, 2% of dry hawthorn slice, 25% of honey and 58% of white rice vinegar.
A preparation method of a ganoderma and lance asiabell compound enzyme comprises the following steps:
(1) Preparing lucid ganoderma and snail egg rice vinegar extracting solution
Weighing 6% of glossy ganoderma and trumpet shell eggs by weight, cleaning, stirring and grinding, weighing 10% of rice vinegar, putting the stirred glossy ganoderma and trumpet shell eggs into the rice vinegar for soaking for 21 days, filtering the soaking solution by using a fine sieve of 200 to 360 meshes, and collecting the filtrate for later use;
(2) Preparation of plant Chinese medicinal rice vinegar extract
Weighing 5% of black wolfberry fruit, 2% of white chrysanthemum, 2% of hawthorn slice, 2% of liquorice and 2% of honeysuckle by weight, respectively cleaning and drying in the air, putting into 48% of rice vinegar by weight, soaking for 21 days, stirring for 1 time every 3 days during soaking, filtering by using a 200-360-mesh fine sieve, and collecting filtrate for later use;
(3) Compound enzyme for preparing ganoderma and lance snail
Adding the ganoderma and lance asiabell egg rice vinegar extract and the plant traditional Chinese medicine rice vinegar extract obtained in the steps (1) and (2) into honey with the weight percentage of 25%, uniformly stirring, sealing and fermenting for 15 days, then putting into a storage tank, sterilizing, filling into a finished product bottle, and sealing and packaging to obtain the ganoderma and lance asiabell compound enzyme.
Example 3: this example differs from examples 1 and 2 in that: the ganoderma and lance rock composite enzyme comprises the following raw materials in percentage by weight: 8% of glossy ganoderma and Chinese wolfberry fruit, 2% of black wolfberry fruit, 1.5% of white chrysanthemum, 1.5% of liquorice, 1.5% of honeysuckle, 1.5% of dry hawthorn slices, 24% of xylitol and 60% of white rice vinegar.
A preparation method of a ganoderma and lance asiabell compound enzyme comprises the following steps:
(1) Preparing lucid ganoderma and snail egg rice vinegar extracting solution
Weighing 8% of glossy ganoderma and trumpet shell eggs by weight, cleaning, stirring and grinding, weighing 10% of rice vinegar, putting the stirred glossy ganoderma and trumpet shell eggs into the rice vinegar for soaking for 30 days, filtering a soaking solution by using a fine sieve of 200 to 360 meshes, and collecting a filtrate for later use;
(2) Preparation of plant Chinese medicinal rice vinegar extract
Weighing 2% of black wolfberry, 1.5% of white chrysanthemum, 1.5% of hawthorn slices, 1.5% of liquorice and 1.5% of honeysuckle by weight, respectively cleaning and drying, putting into 46% of rice vinegar by weight, soaking for 30 days, stirring for 3 times every day during soaking, filtering by using a 200-360-mesh fine sieve, and collecting filtrate for later use;
(3) Preparation of lucid ganoderma and concha delavayi complex enzyme
Adding the ganoderma and lance asiabell egg rice vinegar extract and the plant traditional Chinese medicine rice vinegar extract obtained in the steps (1) and (2) into xylitol with the weight percentage of 24%, uniformly stirring, placing into a storage tank after sealed fermentation for 15 days, filling into a finished product bottle after sterilization, and sealing and packaging to obtain the ganoderma and lance asiabell compound enzyme.
The eggs of the ganoderma lucidum and the lance asiabell root adopted by the invention are eggs produced by the lance asiabell root which is specially used for eating the ganoderma lucidum, the ganoderma lucidum and the lance asiabell root are artificially cultured and specially used for eating the ganoderma lucidum powder, and more than 30 kinds of ganoderma lucidum and lance asiabell root eggs contain bioactive enzymes and bioactive peptides, so that various nutritional ingredients are fully and effectively absorbed and utilized to meet the requirements of human bodies. The ganoderma lucidum and lance rock complex enzyme active enzyme and the active peptide can promote physiological activities of nerves, digestion, internal circulation, reproduction, internal secretion and the like of a human body; proved by clinical tests and examinations, the product contains the extract of various plant Chinese medicines, wherein the extract contains 18 amino acids, acetic acid, malic acid, ascorbic acid, nicotinic acid, potassium, sodium, calcium, magnesium, iron, copper, zinc, manganese, phosphorus, boron, selenium and other trace elements essential for human bodies, various vitamins, crude polysaccharide, flavone, crude fiber, carotene and other nutrient body bodies; and nicotinic acid can effectively promote the discharge of cholesterol through intestinal tracts, so that the content of cholesterol in blood and body tissues is reduced. The oral liquid has effects in relieving sore throat, moistening throat, clearing away heat and toxic materials, dilating coronary artery, and increasing coronary artery flow; and has effects of lowering blood pressure, diluting blood lipid, reducing myocardial consumption, lowering blood sugar, protecting liver, and resisting anoxia.
In the above 3 embodiments, embodiment 3 is the most preferred embodiment.
Finally, it should be noted that: the above embodiments are merely illustrative and not restrictive of the technical solutions of the present invention, and any equivalent substitutions and modifications or partial substitutions made without departing from the spirit and scope of the present invention should be included in the scope of the claims of the present invention.
Claims (5)
1. A ganoderma lucidum and lance snail compound enzyme is characterized in that: comprises the following raw materials in percentage by weight: 5-8% of glossy ganoderma and Chinese snail eggs, 2-3% of black wolfberry fruits, 1.5-2% of white chrysanthemum or wild chrysanthemum flowers, 1-2% of liquorice, 1-2% of honeysuckle, 1-2% of dry hawthorn slices, 24-28% of red fresh sugar alcohol, 24-28% of honey or xylitol and 58-60% of white rice vinegar.
2. The enzyme ferment of ganoderma lucidum and lance asiabell root complex enzyme according to claim 1, which is characterized in that: comprises the following raw materials in percentage by weight: 5% of glossy ganoderma and Chinese wolfberry fruit, 2% of white chrysanthemum, 1% of liquorice, 1% of honeysuckle, 1% of dry hawthorn slice, 28% of red fresh sugar alcohol and 60% of white rice vinegar.
3. The enzyme ferment of ganoderma lucidum and lance asiabell root complex enzyme according to claim 1, which is characterized in that: comprises the following raw materials in percentage by weight: 6% of glossy ganoderma and Chinese wolfberry fruit, 3% of black wolfberry fruit, 2% of wild chrysanthemum flower, 2% of liquorice, 2% of honeysuckle, 2% of dry hawthorn slice, 25% of honey and 58% of white rice vinegar.
4. The enzyme ferment of ganoderma lucidum and lance asiabell root complex enzyme according to claim 1, which is characterized in that: comprises the following raw materials in percentage by weight: 8% of glossy ganoderma and Chinese wolfberry fruit, 2% of black wolfberry fruit, 1.5% of white chrysanthemum, 1.5% of liquorice, 1.5% of honeysuckle, 1.5% of dry hawthorn slices, 24% of xylitol and 60% of white rice vinegar.
5. The preparation method of the ganoderma lucidum and lance asiabell root complex enzyme according to claim 1, which is characterized by comprising the following steps: the method comprises the following steps:
(1) Preparing lucid ganoderma and snail egg rice vinegar extracting solution
Weighing 5-8% of glossy ganoderma snail eggs by weight, cleaning, stirring and grinding, weighing 10-15% of rice vinegar, putting the stirred and ground glossy ganoderma snail eggs into the rice vinegar for soaking for 15-30 days, filtering the soaking solution by using a 200-to-360-mesh fine sieve, and collecting the filtrate for later use;
(2) Preparation of plant traditional Chinese medicine rice vinegar extract
Weighing 2-3% of black wolfberry, 1.5-2% of white chrysanthemum, 1-2% of hawthorn slices, 1-2% of liquorice and 1-2% of honeysuckle according to weight percentage, respectively cleaning and airing, putting into 45-48% of rice vinegar for soaking for 15-30 days, stirring for 1-3 times every 1-5 days during soaking, filtering by using a 360-mesh sieve of minus 200 meshes, and collecting filtrate for later use;
(3) Compound enzyme for preparing ganoderma and lance snail
Adding the ganoderma and lance asiabell egg rice vinegar extract and the plant traditional Chinese medicine rice vinegar extract obtained in the steps (1) and (2) into 24-28 wt% of erythritol, honey or xylitol, uniformly stirring, sealing and fermenting for 15 days, then placing into a storage tank, sterilizing, filling into a finished product bottle, and sealing and packaging to obtain the ganoderma and lance asiabell complex enzyme.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210846398.5A CN115227748A (en) | 2022-07-19 | 2022-07-19 | Lucid ganoderma and lance asiabell root compound enzyme and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210846398.5A CN115227748A (en) | 2022-07-19 | 2022-07-19 | Lucid ganoderma and lance asiabell root compound enzyme and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115227748A true CN115227748A (en) | 2022-10-25 |
Family
ID=83673161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210846398.5A Pending CN115227748A (en) | 2022-07-19 | 2022-07-19 | Lucid ganoderma and lance asiabell root compound enzyme and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115227748A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108142872A (en) * | 2017-12-26 | 2018-06-12 | 重庆医学检验试剂研究所 | A kind of Pomacea canaliculata ovum can and preparation method thereof |
| CN111631401A (en) * | 2020-06-09 | 2020-09-08 | 承德医学院 | Traditional Chinese medicine enzyme and preparation method thereof |
-
2022
- 2022-07-19 CN CN202210846398.5A patent/CN115227748A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108142872A (en) * | 2017-12-26 | 2018-06-12 | 重庆医学检验试剂研究所 | A kind of Pomacea canaliculata ovum can and preparation method thereof |
| CN111631401A (en) * | 2020-06-09 | 2020-09-08 | 承德医学院 | Traditional Chinese medicine enzyme and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 李秀才: "《冠心病自然疗法》", 河南科学技术出版社, pages: 40 * |
| 海南日报: "五指山市毛纳村产业发展和乡村环境建设两翼齐飞 美丽黎村引客来", pages 258 - 259 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103110162B (en) | Vegetable protein drink containing seeds of paeonia suffruticosa and preparation method of drink | |
| CN106721717B (en) | A preparation method of fructus Jujubae juice or fructus Jujubae concentrated clear juice containing high water soluble dietary fiber | |
| CN105167072A (en) | Production method of functional Chinese wolfberry fruit enzyme and product thereof | |
| CN107518390A (en) | A kind of beautiful ferment of promise and preparation method thereof | |
| CN102242070A (en) | Method for artificially culturing paecilomyces cicadae and application of culturing product thereof | |
| CN101245307A (en) | Melon and fruit vinegar and manufacture method thereof | |
| CN104928113A (en) | Compound fermentation type pear heath care wine and production technology thereof | |
| CN111035002A (en) | Preparation method of saponin rice enzyme | |
| CN102813193A (en) | Chinese caterpillar fungus cyanine oral liquid and preparation method thereof | |
| CN102805150A (en) | Live bacteria type lotus seed and corn yoghurt beverage and preparation method thereof | |
| CN105146402A (en) | Preparation method of purple sweet potato enzyme powder | |
| CN103184122A (en) | Production process for peony-cherry fermented fruit wine | |
| CN107307407A (en) | A kind of fruit ferment drink | |
| CN103054096A (en) | A biological fermented dark chestnut and a preparation method thereof | |
| CN100488381C (en) | Propolis ganoderma lucidum spore, dried black fungus polysaccharide compounded soft capsule and preparing process therefor | |
| CN102599512B (en) | Sea buckthorn nutrition powder and preparation method thereof | |
| CN106497722B (en) | Walnut flower pomegranate fruit wine and preparation method thereof | |
| CN112516017B (en) | Method for manufacturing edible-grade chenopodium album mycelium mask | |
| CN115227748A (en) | Lucid ganoderma and lance asiabell root compound enzyme and preparation method thereof | |
| CN104413320A (en) | Nymphaea-tetragona-flower red-date jelly | |
| CN106418498A (en) | Method for preparing enzyme by using lemons and galangal as main materials | |
| CN106962716B (en) | Lucid ganoderma germinated brown rice fruit and vegetable beverage and preparation method thereof | |
| CN105249090A (en) | Anti-wrinkle beauty-maintaining enzyme drink and preparation method therefor | |
| CN108902950A (en) | A kind of wild vegetables enzyme beverage and preparation method | |
| CN103589569B (en) | Production technique of compound fermented ulva health wine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221025 |
|
| RJ01 | Rejection of invention patent application after publication |